To the full analysis
Medartis Holding stock: growth
MED.SWMedartis Holding reported $323.18M in revenue for fiscal 2025, up 19.8% on the prior year, up 16.1% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
12.6%
per year from 2015 to 2025, per share 12%
Earnings (Annual rate)
1.4%
per year from 2015 to 2025, per share 0.8%
Free cash flow (Annual rate)
27.5%
per year from 2015 to 2025, per share 26.8%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | |
|---|---|---|
| Revenue | 16.1% | 12.6% |
| Revenue per share | 14.9% | 12.0% |
| Earnings | no data | 1.4% |
| Earnings per share | no data | 0.8% |
| Free cash flow | no data | 27.5% |
| Free cash flow per share | no data | 26.8% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2015 | $98.79M | $8.73M | $986.58K |
| 2016 | $111.03M | $3.98M | $4.06M |
| 2017 | $126.08M | $1.04M | $2.67M |
| 2018 | $145.62M | $5.04M | −$9.64M |
| 2019 | $156.21M | $2.58M | −$13.58M |
| 2020 | $153.21M | −$1.13M | −$546.47K |
| 2021 | $191.9M | $8.21M | $12.68M |
| 2022 | $219.44M | −$6.94M | −$27.27M |
| 2023 | $254.47M | $742.97K | $6.06M |
| 2024 | $269.86M | $4.23M | $25.21M |
| 2025 | $323.18M | $10.02M | $11.21M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = CHF 0.8331)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 18 Oct 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.